Eileen Francis

Eileen Francis

Senior Reporter

Washington, DC

Eileen tracks developments in OTC drug research, manufacturing, regulation, finance, M&A and marketing. She favors stories on e-commerce trends and the industry's drive toward Rx-to-OTC drug switches. Eileen also contributes coverage on the dietary supplement industry. She has a keen eye for pieces that delve into the rising self-care movement and how it is raising the innovation bar for marketers.

Latest from Eileen Francis

Factorfive’s Stem Cell-Based Skin Care Benefits Exceed Promotional Claims – CEO

Xytogen Biotech’s Factorfive stem cell-based skin care delivers benefits that are greater than the company claims, says founder and CEO John Aylworth. Available mostly through clinicians’ offices, the formulas are based on a proprietary process that triggers stem cells to send out growth factor signals, which are captured in a ‘conditioned media’ and used as the basis for products.

E.l.f. Beauty ‘Highly Confident’ In Navigating Potential Trump Tariffs; ‘Levers At Our Disposal’

E.l.f. Beauty isn’t worried about potential tariffs imposed under the incoming Trump Administration, as it is less reliant on products from China than it was during 2018/2019 tariffs and has a playbook ‘and a number of levers at our disposal’ to mitigate the cost impact.

ECHA Urges Industry: ‘Pay Attention To REACH’ After Finding 6% Of Cosmetics Contain Banned Chemicals

The European Chemicals Agency’s Forum for Exchange of Information on Enforcement is encouraging cosmetics companies to brush up on the provisions of REACH and a European regulation on persistent organic pollutants after it found 6.4% of nearly 4,500 cosmetic products contain banned hazardous chemicals.

Estee Lauder Pulls FY 2025 Guidance; Macro Headwinds Worse Than Expected

The Estee Lauder Companies, Inc.’s Mainland China business weakened ‘substantially’ from a 10% decline in Q4, prompting the firm to pull its fiscal year 2025 sales outlook and forecasting reported and organic net sales in the fiscal second quarter will fall 6%-8%.

Estee Lauder Shake-Up: Internal Exec Named CEO As William Lauder Steps Down As Exec Chair

The Estee Lauder Companies Inc. says new president and CEO Stéphane de la Faverie will lead in nurturing and building powerful prestige brands while also moving the firm forward “with speed and urgency.” William Lauder announces plans to step down from his role as executive chairman, while Jane Lauder reportedly has also decided to exit.

Cosmetics Industry Q3: Cetaphil Investments Drive Galderma Derm Division; Inflation Impacting Direct-To-Consumer Sales; More

Galderma Group AG’s investments in Cetaphil launch, ‘re-energizing’ of brand pay off with sales of the dermatology unit up 10.6% in the third quarter. Separately, Spanish beauty company Puig reports its Fragrance and Fashion business grew 11.1% and its makeup division advanced 7.3% in the quarter, while data insights company Consumer Edge identifies slowdown in direct-to-consumer beauty sales.